Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.30 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13088703 | 0.94 | ENPP2 (0.53) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL12568525 | 0.94 | ENPP2 (0.53) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL13860911 | 0.94 | ENPP2 (0.53) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL12606547 | 0.91 | ENPP2 (0.61) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL12975926 | 0.91 | ENPP2 (0.61) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL13088667 | 0.89 | ENPP2 (0.46) | ENPP2ALDH1A1MAPTPHLPP2PTPN1 | |
| SCHEMBL13088664 | 0.88 | ENPP2 (0.46) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL13088662 | 0.88 | ENPP2 (0.46) | ENPP2MEN1ALDH1A1POLBMAPT | |
| SCHEMBL13815199 | 0.86 | ENPP2 (0.63) | ENPP2ALDH1A1PHLPP2PTPN1CARM1 | |
| SCHEMBL14001675 | 0.85 | ENPP2 (0.43) | ENPP2MEN1ALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7445822-B2 | Azo compounds and dye-type polarizing films or plates containing the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-11-04 | — | — | US | disclosed |
| US-20080094549-A1 | Azo Compounds And Dye-Type Polarizing Films Or Plates Containing The Same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080094549-A1 | Azo Compounds And Dye-Type Polarizing Films Or Plates Containing The Same | CRY1, SCO2, SPR | ENPP2 1986/4885MEN1 2570/4885ALDH1A1 1256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.